Invivyd Inc
Follow $IVVD
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $IVVD by emailVeridion Score
BETAMEDIUM CONF · 5 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is IVVD moving today?
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
IVVD overview
Related filings and maps
Congress activity in IVVD
No receipt-qualified Congressional disclosure is present for IVVD in the cached public ledger.
IVVD contract awards, year to date.
Public federal awards linked to this ticker.
IVVD lobbying filings, year to date.
Registered lobbying filings matched to Invivyd Inc.
FORBES-TATE
INVIVYD, INC.
FORBES-TATE